TDTP-RECIST

Clinical trials for TDTP-RECIST explained in plain language.

Never miss a new study

Get alerted when new TDTP-RECIST trials appear

Sign up with your email to follow new studies for TDTP-RECIST, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New tool could guide surgery timing for tough liver cancer

Disease control Not yet recruiting

This study looks at 270 people with a type of liver cancer (intrahepatic cholangiocarcinoma) that cannot be removed right away. After initial chemotherapy (GOLP regimen), participants are split into three groups: one continues medication, one goes straight to surgery, and one use…

Matched conditions: TDTP-RECIST

Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control

Last updated Jun 27, 2026 07:54 UTC

TDTP-RECIST

Get alerted when new TDTP-RECIST trials appear

New tool could guide surgery timing for tough liver cancer